characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2018-03-18T17:02:42Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2016-03-17T11:59:14Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA3903306
characteristics.characteristic: External Id
characteristics.text: National Public Health Laboratory
characteristics.characteristic: INSDC center name
characteristics.text: 2018-03-18T17:02:42Z
characteristics.characteristic: INSDC first public
characteristics.text: 2016-03-17T11:59:14Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS1090440
characteristics.characteristic: SRA accession
characteristics.text: Delftia strain 2189
characteristics.characteristic: Submitter Id
characteristics.text: The excessive global use of antimicrobial drugs in humans as well as agriculture and veterinary medicine has led to the emergence of new multidrug resistant pathogens. Many of these pathogens are globally spread and treatment options for clinicians are becoming limited. Our research indicates that Delftia spp. produce novel anti-bacterial compounds active against Gram positive and Gram negative multidrug resistant pathogens.
characteristics.characteristic: description
characteristics.text: Delftia acidovorans
characteristics.characteristic: organism
characteristics.text: Delftia acidovorans
characteristics.characteristic: scientific_name
characteristics.text: Isolation of antimicrobial compounds from the genus Delftia.
characteristics.characteristic: title